GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shanghai Jiaoda Onlly Co Ltd (SHSE:600530) » Definitions » Capex-to-Revenue

Shanghai Jiaoda Onlly Co (SHSE:600530) Capex-to-Revenue : 0.03 (As of Mar. 2024)


View and export this data going back to 2001. Start your Free Trial

What is Shanghai Jiaoda Onlly Co Capex-to-Revenue?

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue.

Shanghai Jiaoda Onlly Co's Capital Expenditure for the three months ended in Mar. 2024 was ¥-2.10 Mil. Its Revenue for the three months ended in Mar. 2024 was ¥75.55 Mil.

Hence, Shanghai Jiaoda Onlly Co's Capex-to-Revenue for the three months ended in Mar. 2024 was 0.03.


Shanghai Jiaoda Onlly Co Capex-to-Revenue Historical Data

The historical data trend for Shanghai Jiaoda Onlly Co's Capex-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai Jiaoda Onlly Co Capex-to-Revenue Chart

Shanghai Jiaoda Onlly Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Capex-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.17 0.09 0.03 0.07 0.03

Shanghai Jiaoda Onlly Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Capex-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.07 0.01 0.02 0.02 0.03

Competitive Comparison of Shanghai Jiaoda Onlly Co's Capex-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Shanghai Jiaoda Onlly Co's Capex-to-Revenue, along with its competitors' market caps and Capex-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shanghai Jiaoda Onlly Co's Capex-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Shanghai Jiaoda Onlly Co's Capex-to-Revenue distribution charts can be found below:

* The bar in red indicates where Shanghai Jiaoda Onlly Co's Capex-to-Revenue falls into.



Shanghai Jiaoda Onlly Co Capex-to-Revenue Calculation

Shanghai Jiaoda Onlly Co's Capex-to-Revenue for the fiscal year that ended in Dec. 2023 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (-9.553) / 296.327
=0.03

Shanghai Jiaoda Onlly Co's Capex-to-Revenue for the quarter that ended in Mar. 2024 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (-2.1) / 75.55
=0.03

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Shanghai Jiaoda Onlly Co  (SHSE:600530) Capex-to-Revenue Explanation

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue. The ratio shows how aggressively the company reinvests its revenue back into productive assets. However, a high ratio potentially indicates that the company has invested too much in innovation and infrastructure, taking up funds that could be used to boost productivity and increase revenue. Therefore, a high Capex to Revenue Ratio could be a positive or a negative sign depending on how effectively a company converts those investments into future earnings.


Shanghai Jiaoda Onlly Co Capex-to-Revenue Related Terms

Thank you for viewing the detailed overview of Shanghai Jiaoda Onlly Co's Capex-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Shanghai Jiaoda Onlly Co (SHSE:600530) Business Description

Traded in Other Exchanges
N/A
Address
No. 700 Yishan Road, Shanghai, Shanghai, CHN, 200233
Shanghai Jiaoda Onlly Co Ltd is engaged in producing and distributing healthcare products. The company is also involved in real estate and financial investment. Its main products are biological products and healthcare products.

Shanghai Jiaoda Onlly Co (SHSE:600530) Headlines

No Headlines